The latest announcement reveals that 15 shares are expected to erupt
Sibao Technology disclosed the 2019 annual performance forecast. The company expects a profit of 127 million to 140 million yuan in 2019, an increase of 95% -115% over the same period last year. During the reporting period, the domestic silicone sealant industry developed well and the company had sufficient sales orders.
Hongta Securities' parent company realized net profit of 193 million yuan last month. Hongta Securities announced that the company's parent company achieved net profit of 193 million yuan in December 2019 and net profit of 69.818 million yuan in November 2019.
Wohua Pharmaceutical's 2019 net profit is expected to increase by 95% -142%
Wohua Pharmaceutical disclosed the 2019 annual performance forecast. The company expects a profit of 89.202425 million yuan-104.4763 million yuan in 2019, an increase of 95% -142% over the same period of the previous year. During the reporting period, the company's refined management level was significantly improved. On the premise of ensuring a steady increase in sales revenue, the cost was significantly reduced.
The net profit of the parent company of Hua'an Securities increased by nearly six times from the previous month's 154 million yuan. Huaan Securities announced that in December 2019, the parent company of the company realized a net profit of 154 million yuan. In November 2019, the net profit was 225.4454 million yuan, an increase of 582.93%.
Linyang Energy plans to implement the second phase of the repurchase plan from 300 million yuan to 600 million yuan. On January 8, the company's board of directors reviewed and approved the second phase of the proposal for repurchasing shares through centralized bidding. The company's repurchase amount is not less than 300 million yuan and not more than 600 million yuan. The repurchase price does not exceed RMB 7.17 per share. The shares to be repurchased will be used to convert corporate bonds issued by the company into convertible shares.
Sifangda's 2019 net profit is expected to increase by 78% -94%
Sifangda disclosed the 2019 annual results forecast. The company expects a profit of 115 million to 125 million yuan in 2019, an increase of 78% -94% over the same period last year.
Tiankang Bio's hog sales revenue in 2019 increased by 111% year-on-year
Tiankang Bio announced that the company sold 73,100 live pigs in December 2019, with sales volume increasing 20.23% month-on-month and 0.83% year-on-year; sales income of 264 million yuan, sales income increasing 44.26% month-on-month and 214.29% year-on-year. From January to December 2019, the company sold a total of 842,700 live pigs, an increase of 30.33% over the same period last year; the accumulated sales income was 1,501 million yuan, an increase of 110.81% over the same period last year.
Shanghai Construction Engineering's spin-off subsidiary Construction Engineering Materials was listed on the main board of the Shanghai Stock Exchange. Shanghai Construction Engineering announced that the company ’s wholly-owned subsidiary, Shanghai Construction Engineering Materials Engineering Co., Ltd. and related entities, after appropriate reorganization, changed the entire construction engineering materials to form a joint stock company. It also submitted the listing application documents to the China Securities Regulatory Commission as the subject of listing. After obtaining the approval, it chose to publicly issue A shares and listed on the main board of the Shanghai Stock Exchange. The main business of the main construction materials of this spin-off is the production and sales of ready-mixed concrete and prefabricated components. It belongs to the business sector of the building materials industry and maintains a high degree of independence from other business segments of the company. After the completion of the spin-off, construction materials are still the company's controlling subsidiaries.
Aier Ophthalmology intends to acquire multiple eye hospitals with a total price of 1.87 billion yuan. Aier Ophthalmology announced that the company intends to purchase 100% equity of Tianjin Cvision by issuing shares, and plans to purchase 100% equity of Allied Vision by issuing shares and paying cash. And Xuancheng Eye Hospital 80% equity, it is planned to purchase 90% equity of Wanzhou Airi and 90% equity of Kaizhou Airi by issuing shares, and the total transaction price of these equity is RMB 18.6898 million. At the same time, the company plans to raise matching funds by issuing shares to no more than 5 specific investors, and the total amount of matching funds will not exceed RMB 710.2 million. This transaction constitutes a major asset reorganization. The company intends to acquire multiple eye hospitals, which is an expansion of the company's original business and will help achieve its own business synergy.
Yibai Pharmaceutical intends to invest 600 million yuan in the construction of a new plant in Mei'an Technology New City to expand the production capacity of anti-tumor drugs Yibai Pharmaceutical announced that the company's wholly-owned subsidiary Chang'an Pharmaceutical's existing production capacity can no longer meet the company's exclusive original research and development of new drugs, Growing market demand for third-generation platinum-based antitumor drugs for injection of loplatin. In order to solve the bottleneck of development and to increase the company's production capacity of chemical drugs including anti-tumor drugs, Chang'an Pharmaceutical intends to invest in the construction of the "Meian Technology New City New Plant Construction Project" in Mei'an Science and Technology New City in Haikou. This project After completion, it will be engaged in the production and operation of related products. The total investment in fixed assets of this project is expected to be 603 million yuan.
Shenzhen Expressway intends not to exceed 810 million yuan in holding Lande Environmental Protection to increase the environmental protection industry, Shenzhen Expressway announces that Shenzhen High-Speed Environment Co., Ltd., a wholly-owned subsidiary of the company, will receive no more than 75 million shares of Lande Environmental Protection at a price of 5.06 yuan per share. Shares, and subscribe for 85 million newly issued shares of Lande Environmental. After the completion of the transaction, the environmental company will eventually obtain Lande Environmental not more than 160 million shares, with a total consideration of not more than 800,960,000 yuan, and a shareholding ratio of 68.1045%. , Lande Environmental Protection will become the company's holding subsidiary. Lande Environmental Protection is mainly engaged in providing customers with systemic comprehensive solutions for municipal organic waste treatment such as kitchen waste and landfill leachate. In 2018, Lande Environmental Protection had a total revenue of 182 million yuan and a net profit of -57.95 million yuan.
Wynn shares Tesla is one of the company's important customers Wynn shares announcement, the company's stock trading price within three consecutive trading days, the daily closing price increase deviated from the cumulative value of more than 20%, which belongs to stock trading abnormal fluctuations. Tesla is one of the company's important customers. In 2019, the company won Tesla's order amount of about 72 million yuan. If the specific matters involved in the future cooperation between the company and Tesla meet the information disclosure standards, the company will issue relevant announcements in a timely manner. Tesla is one of the company's automotive molding customers. It is not fundamentally different from other customers of FAW Toyota, BMW Brilliance, Changan Mazda, Shanghai GM, Beijing Benz and other companies. At the same time, the company's business cooperation with Tesla has market development risks, and the company reminds investors to pay attention to investment risks.
Tesla's share price of Xusheng shares changed. As the company's largest customer, Xusheng shares announced that the company's shares had a closing price increase of more than three consecutive trading days on Jan. 6, Jan. 7, and Jan. 2020. 20%. At present, Tesla is the company's largest customer. As of the first half of 2019, the company's sales revenue to Tesla accounted for 52.09% of its main business revenue. After self-examination, the company is currently cooperating with Tesla normally. No media reports or market rumors that need clarification or response have been found.
Jinjiang Hotel sells approximately 67 million yuan in pre-increased proceeds from the sale of Xi'an Jinjiang Star and Zhengzhou Jinjiang Star. Jinjiang Hotel announced that the hotel investment company, a wholly-owned subsidiary of Jinjiang Hotel , will publicly transfer 100% equity of Xi'an Jinjiang Star on December 2, 2019. 100% equity of Zhengzhou Jinjiang Inn. On January 8, 2020, the hotel investment company and related party Guangshao Company respectively signed the "Shanghai Property Rights Transaction Contract" on the transfer of equity of Xi'an Jinjiang Star and Zhengzhou Jinjiang Star. The transaction price of this transaction was determined based on the recorded evaluation value on December 31, 2018 as the evaluation base date, which were RMB 75,193,051.99 and 60,168,475.98, respectively. The transaction is expected to generate pre-tax income of approximately 67 million yuan. After the completion of the transaction, the hotel investment company no longer holds the equity of Xi'an Jinjiang Star and Zhengzhou Jinjiang Star.
Saifutian was identified as a national intellectual property advantage enterprise . Saifutian announced that the company was identified as a "national intellectual property advantage enterprise" for a period from December 2019 to November 2022. The result of this determination is affirmation of the company's achievements in the field of intellectual property over the years. In the future, the company will continue to devote itself to the innovative research and development of special steel wire ropes and rigging, maintain a leading position in technology , and enhance the company's core competitiveness.